Methyl Prednisolone in Tablet Form is available in 4mg and 16mg strength. The Tablet prevents the rejection of transplanted organs and tissues. Mercury Medicare is the manufacturer of Methyl Prednisolone in Tablet Form.
Mercury Medicare offers multiple ranges of cancer injectables, anti cancer injectables, generic cancer injectables, antibiotic injectables and anti infective injectables. Methyl Prednisolone in Tablet Form is available in 10 X 10 packs. The Tablet is also used for the treatment of autoimmune diseases.